Your browser doesn't support javascript.
loading
Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort.
García-Sánchez, Ainhoa; Sotolongo-Grau, Oscar; Tartari, Juan Pablo; Sanabria, Ángela; Esteban-De Antonio, Ester; Pérez-Cordón, Alba; Alegret, Montserrat; Pytel, Vanesa; Martínez, Joan; Aguilera, Núria; de Rojas, Itziar; Cano, Amanda; García-González, Pablo; Puerta, Raquel; Olivé, Clàudia; Capdevila, Maria; García-Gutiérrez, Fernando; Vivas, Assumpta; Gómez-Chiari, Marta; Giménez, Juan; Tejero, Miguel Ángel; Castilla-Martí, Miguel; Castilla-Martí, Luis; Tárraga, Lluís; Valero, Sergi; Ruiz, Agustín; Boada, Mercè; Marquié, Marta.
  • García-Sánchez A; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Sotolongo-Grau O; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Tartari JP; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Sanabria Á; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Esteban-De Antonio E; CIBERNED, Center for Networked Biomedical Research On Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.
  • Pérez-Cordón A; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Alegret M; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Pytel V; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Martínez J; CIBERNED, Center for Networked Biomedical Research On Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.
  • Aguilera N; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • de Rojas I; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Cano A; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • García-González P; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Puerta R; CIBERNED, Center for Networked Biomedical Research On Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.
  • Olivé C; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Capdevila M; CIBERNED, Center for Networked Biomedical Research On Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.
  • García-Gutiérrez F; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Vivas A; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Gómez-Chiari M; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Giménez J; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Tejero MÁ; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.
  • Castilla-Martí M; Department of Diagnostic Imaging, Clínica Corachan, Barcelona, Spain.
  • Castilla-Martí L; Department of Diagnostic Imaging, Clínica Corachan, Barcelona, Spain.
  • Tárraga L; Department of Diagnostic Imaging, Clínica Corachan, Barcelona, Spain.
  • Valero S; Department of Diagnostic Imaging, Clínica Corachan, Barcelona, Spain.
  • Ruiz A; Clínica Oftalmológica Dr. Castilla, Barcelona, Spain.
  • Boada M; Vista Alpina Eye Clinic, Visp, Switzerland.
  • Marquié M; PhD Programme in Surgery and Morphological Sciences, Universitat Autònoma de Barcelona, Barcelona, Spain.
Alzheimers Res Ther ; 16(1): 42, 2024 02 20.
Article en En | MEDLINE | ID: mdl-38378643
ABSTRACT

INTRODUCTION:

Optical coherence tomography angiography (OCT-A) is a novel tool that allows the detection of retinal vascular changes. We investigated the association of macular vessel density (VD) in the superficial plexus assessed by OCT-A with measures of cerebrovascular pathology and atrophy quantified by brain magnetic resonance imaging (MRI) in non-demented individuals.

METHODS:

Clinical, demographical, OCT-A, and brain MRI data from non-demented research participants were included. We analyzed the association of regional macular VD with brain vascular burden using the Fazekas scale assessed in a logistic regression analysis, and the volume of white matter hyperintensities (WMH) assessed in a multiple linear regression analysis. We also explored the associations of macular VD with hippocampal volume, ventricle volume and Alzheimer disease cortical signature (ADCS) thickness assessed in multiple linear regression analyses. All analyses were adjusted for age, sex, syndromic diagnosis and cardiovascular variables.

RESULTS:

The study cohort comprised 188

participants:

89 with subjective cognitive decline and 99 with mild cognitive impairment. No significant association of regional macular VD with the Fazekas categories (all, p > 0.111) and WMH volume (all, p > 0.051) were detected. VD in the nasal quadrant was associated to hippocampal volume (p = 0.007), but no other associations of macular VD with brain atrophy measures were detected (all, p > 0.05).

DISCUSSION:

Retinal vascular measures were not a proxy of cerebrovascular damage in non-demented individuals, while VD in the nasal quadrant was associated with hippocampal atrophy independently of the amyloid status.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vasos Retinianos / Tomografía de Coherencia Óptica Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vasos Retinianos / Tomografía de Coherencia Óptica Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article